{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA207777"
        ],
        "brand_name": [
          "APREPITANT"
        ],
        "generic_name": [
          "APREPITANT"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-112",
          "68462-583",
          "68462-584",
          "68462-585"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "403810",
          "403811",
          "644088",
          "754508"
        ],
        "spl_id": [
          "41f97256-ac39-413d-8b2f-5fb7ad429143"
        ],
        "spl_set_id": [
          "d72e0e10-4557-41b0-b65d-d395468cad19"
        ],
        "package_ndc": [
          "68462-583-11",
          "68462-583-85",
          "68462-583-40",
          "68462-584-58",
          "68462-584-40",
          "68462-584-76",
          "68462-585-40",
          "68462-585-76",
          "68462-112-33",
          "3684625834"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462585764",
          "0368462112335",
          "0368462584767",
          "0368462583401",
          "368462583401"
        ],
        "nui": [
          "N0000010262",
          "N0000175786",
          "N0000182141",
          "N0000185507",
          "N0000185506"
        ],
        "pharm_class_moa": [
          "Neurokinin 1 Antagonists [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inducers [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]"
        ],
        "pharm_class_epc": [
          "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
        ],
        "unii": [
          "1NF15YR6UY"
        ]
      },
      "product_type": "Drugs",
      "event_id": "81639",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0349-2019",
      "product_description": "Aprepitant Capsules, USP 40 mg,  1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40",
      "product_quantity": "5,016 blister packs",
      "reason_for_recall": "Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.",
      "recall_initiation_date": "20181127",
      "center_classification_date": "20190107",
      "termination_date": "20190912",
      "report_date": "20181226",
      "code_info": "Lot: 17180918, EXP June 2020",
      "more_code_info": ""
    }
  ]
}